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Abstract
Pseudomonas aeruginosa is an opportunistic pathogen that chronically infects the airways of cystic fibrosis (CF) patients and
undergoes a process of genetic adaptation based on mutagenesis. We evaluated the role of mononucleotide G:C and A:T
simple sequence repeats (SSRs) in this adaptive process. An in silico survey of the genome sequences of 7 P. aeruginosa
strains showed that mononucleotide G:C SSRs but not A:T SSRs were greatly under-represented in coding regions,
suggesting a strong counterselection process for G:C SSRs with lengths .5 bp but not for A:T SSRs. A meta-analysis of
published whole genome sequence data for a P. aeruginosa strain from a CF patient with chronic airway infection showed
that G:C SSRs but not A:T SSRs were frequently mutated during the infection process through the insertion or deletion of
one or more SSR subunits. The mutation tendency of G:C SSRs was length-dependent and increased exponentially as a
function of SSR length. When this strain naturally became a stable Mismatch Repair System (MRS)-deficient mutator, the
degree of increase of G:C SSRs mutations (5-fold) was much higher than that of other types of mutation (2.2-fold or less).
Sequence analysis of several mutated genes reported for two different collections, both containing mutator and non-
mutator strains of P. aeruginosa from CF chronic infections, showed that the proportion of G:C SSR mutations was
significantly higher in mutators than in non-mutators, whereas no such difference was observed for A:T SSR mutations. Our
findings, taken together, provide genome-scale evidences that under a MRS-deficient background, long G:C SSRs are able to
stochastically bias mutagenic pathways by making the genes in which they are harbored more prone to mutation. The
combination of MRS deficiency and virulence-related genes that contain long G:C SSRs is therefore a matter of concern in P.
aeruginosa CF chronic infection.
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Introduction
Pseudomonas aeruginosa is an opportunistic pathogen that chron-
ically infects the lungs and airways of cystic fibrosis (CF) patients
and persists by undergoing a genetic adaptation based on
mutagenic processes [1]. Mononucleotide simple sequence repeats
(SSRs) are known to function as mutagenic hotspots within genes
or gene regulatory regions [2,3] and may therefore play an
important role in this mutagenic adaptive process.
The mutagenic properties of mononucleotide SSRs have been
studied in several individual genes and found to vary among
species. Long mononucleotide SSRs are under-represented in the
genomes of bacteria and show signs of strong counterselection at
lengths greater than 7-8 bp [4,5]. In an in vitro study of the factors
involved in the mutagenic process of a specific gene, we
demonstrated recently that a Mismatch Repair System (MRS)-
deficient mutator strain of P. aeruginosa (this type of mutator is
typically found in CF chronic infections [6]) differed in its
mutagenic spectrum from its wild-type counterpart and that
mutations are biased toward mononucleotide G:C SSRs under this
mutator background and are therefore hotspots for mutagenesis
[7,8]. No study to date has attempted to analyze simultaneously
the functional relevance of all the SSRs of a specific organism
during the process of genetic adaptation to a particular environ-
ment. There have also been no genome-scale studies on SSRs in P.
aeruginosa.
We initially used publicly available software tools to analyze the
frequency and distribution of mononucleotide G:C and A:T SSRs
in the coding and non-coding genome regions of 7 P. aeruginosa
strains whose genome sequences and annotations are available
online. We then investigated the role of these mononucleotide
SSRs in the pathogenic adaptive process of P. aeruginosa to the
chronic lung infection environment of CF patients. For this
purpose, we performed a meta-analysis on published whole-
genome sequence data from a single P. aeruginosa strain that had
been sequentially isolated from the airways of a CF patient during
a 90-month period [1]. This strain eventually became a MRS-
deficient mutator, a condition that may enhance the genetic
adaptation to the airways of CF patients [9]. We analyzed
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separately the roles of G:C and A:T SSRs before and after this
strain attained the mutator state.
Our findings suggest that (i) G:C SSRs but not A:T SSRs show
signs of a counterselection process in the genomic coding regions
of P. aeruginosa and (ii) under a MRS-deficient mutator back-
ground, the G:C SSRs constitute an important pathway in the
mutation-based adaptation of P. aeruginosa to the chronic lung
infection environment of CF patients.
Results and Discussion
Mononucleotide SSRs in the genome of P. aeruginosa:
G:C but not A:T SSRs show signs of a counterselection
process
To clarify the role of mononucleotide SSRs in the genetic
adaptation of P. aeruginosa, we first evaluated the SSR content in
the genomic sequences of 7 P. aeruginosa strains. These genomes
varied in size from 6.2 to 6.9 Mb and had a G:C content of
,67%. Assuming that nucleotides are randomly distributed and
that homopolymeric SSRs are neutral objects along the genome,
their frequencies should be similar to those obtained from random
predictive models. Based on this assumption, we performed an in
silico genome-wide search of homopolymeric SSRs and compared
the observed frequencies of mononucleotide SSRs with the values
obtained from 8 previously described random predictive models
[10]. The results for strains PAO1 and PACS2 are shown in
Figure 1 and S1, respectively. The results for strains PA14,
LESB58, 2192, 39016, and PA7 were similar (data not shown).
The observed frequencies of short homopolymeric SSRs (length
#4 bp) did not differ from the expected values of a random
distribution, whereas longer SSRs were clearly under-represented
in the 7 analyzed genomes and SSRs with lengths $9 bp were
absent. By distinguishing between G:C and A:T SSRs, we found
that the under-representation of long homopolymeric SSRs was
attributable exclusively to the G:C SSRs and that the frequencies
of G:C SSRs with lengths .5 bp were significantly lower than the
Figure 1. Mononucleotide SSRs in the P. aeruginosa PAO1 genome. The plots show the counts for mononucleotide SSRs (red circles) in the
whole P. aeruginosa PAO1 genome and in random sequences generated by various predictive models (black symbols). b and m1: homogeneous
models (Bernoulli and first-order Markov); b-b, b-bp, m1-m1, m1-m1p, m1-c and m1-c1: heterogeneous models (see Methods). Counts are shown of
mononucleotide G:C and A:T SSRs in the coding and non-coding regions of the genome.
doi:10.1371/journal.pone.0080514.g001
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expected values of a random distribution (Figure 1 and S1). This
finding suggests that G:C SSRs have great intrinsic replicative
instability and/or are subjected to a strong counterselective
pressure, as has been observed for other bacterial species [4]. In
regard to A:T SSRs, our analysis showed no under-representation
even for SSRs with lengths up to 9 bp, and the frequencies were
consistent with those from the random predictive models. This
latter finding could have resulted from an over-representation of
A:T SSRs in intergenic regions that masked a possible under-
representation in coding DNA. To evaluate the role of selection in
the observed representation of G:C and A:T SSRs, we evaluated
the content of G:C SSRs in the coding regions (in which most
selection occurs) and non-coding regions of the genome, and
compared these values with the expected values from random
models for both regions. If the observed under-representation
resulted mainly from genetic instability during DNA replication,
then we would expect to observe similar contents of G:C SSRs in
the coding and non-coding regions. In fact, under-representation
of G:C SSRs with lengths .4 bp was prominent in the coding
regions but much less so in the non-coding regions (Figure 1 and
S1) [4]. In regard to A:T SSRs, previous studies of other bacteria,
such as Escherichia coli and Mycobacterium tuberculosis, showed that the
above phenomenon was much less prominent than for G:C SSRs
because the A:T SSRs had greater stability and lower mutation
rates in comparison to the G:C SSRs, and clear under-
representation was observed only for SSRs with lengths .6 bp
[4,11]. The high overlap between the number of intragenic A:T
SSRs that we observed and the numbers predicted by the random
models is interesting because it suggests a lack of selection against
the occurrence of A:T SSRs within the genome coding regions of
P. aeruginosa.
Our genome-level approach using an in silico genome-wide
survey of mononucleotide SSRs is the first exhaustive analysis of
this type applied to P. aeruginosa. Mononucleotide G:C SSRs are
under-represented in P. aeruginosa, similarly to previous observa-
tions for E. coli and other bacteria [4,5,11,12]. This phenomenon
was much more prominent in coding regions than in non-coding
regions of the genome (Figure 1 and S1). Although an intrinsic
replicative instability of G:C SSRs could partially account for their
under-representation, it is clear that G:C runs in P. aeruginosa are
strongly counterselected in the coding DNA. This finding suggests
that the G:C SSRs that are maintained in the coding regions are of
functional/evolutionary relevance because they make certain
genes more prone to mutation than others.
SSRs constitute a major pathway for adaptive
mutagenesis during CF chronic infection
In the context of CF chronic infection, the above findings posed
the question whether mononucleotide SSRs play a role in genetic
adaptation of P. aeruginosa to the airways of CF patients. To
elucidate the role of SSRs in an in vivo context, we performed a
meta-analysis of published data from whole-genome sequencing of
two P. aeruginosa CF isolates from the same patient that were
obtained 90 months apart [1]. This 2006 study revealed the
genetic changes that made possible the long-term adaptation of
this P. aeruginosa strain (referred to as PACS2) to the CF lung
environment. We used the data from the 2006 study to evaluate
the involvement of mononucleotide SSRs in this adaptive process
by analyzing 85 independent mutational events (mutations m1-
m68 and s1-s17) that occurred in the coding sequences of 60 genes
and 9 intergenic regions [1]. More than half of these mutations
consisted of some type of base substitution (Figure 2). The other
large category of alterations was the insertion/deletion ("indel")
mutations, the majority of which (91%) occurred in some type of
SSR through the addition or deletion of one or more repeating
units of the SSR. The indel mutations found in SSRs most
frequently occurred in mononucleotide G:C SSRs (Figure 2).
Of the 60 genes analyzed, the number of those that carried
mononucleotide G:C SSRs decreased exponentially (with a
common ratio of ,5.6) with the corresponding increase in SSR
length (Figure 3A). When we considered only those genes
harboring G:C SSRs that were mutated during the infection
process, the proportion increased notably with the size of the SSR.
This finding suggests that even for a heterogeneous group of genes
the capacity of G:C SSRs to make genes more prone to mutation
was size-dependent. Previous studies on the role of SSRs were
restricted to single SSRs involved in the acquisition of specific
phenotypes [4,7,8,9,10]. It was therefore possible to assess the
more general impact of SSR mutagenesis only by gathering
information from various studies of individual cases. Surprisingly,
of the 5 G:C SSRs of length 8 bp that were observed in the whole
coding DNA of the PACS2 genome, 3 were present within the 60
genes and were mutated during the CF infection process. The A:T
SSRs did not display this phenomenon or any association between
SSR length and mutagenesis (Figure 3B).
As another indicator of the functional relevance of SSRs during
CF chronic infection, we scored the content of G:C and A:T SSRs
in a 99% prediction region, for SSRs of length 1 to 9 bp, that was
estimated by a re-sampling technique. A set of 50000 samples
containing 60 genes each (the number of genes in the pool of
mutated genes) was randomly taken from the whole coding
genome of P. aeruginosa PACS2 (see Materials and Methods),
thereby providing a good estimation of empirical distributions of
mononucleotide SSR counts. We determined whether the
frequencies of the G:C and A:T SSRs of every length in the pool
of 60 mutated genes fell inside or outside the prediction region
generated by the 50000 random samples. Among the 60 mutated
genes, the frequencies of G:C SSRs with length #7 bp fell within
the area of the prediction region (Figure 4A). The frequency of
Figure 2. Genetic changes in P. aeruginosa PACS2. The pie-chart
shows the distribution of 85 independent mutational events that
occurred in the genome of P. aeruginosa strain PACS2 during the
process of chronic infection, as reported by Smith et al. [1]. Percentages
are shown of base substitutions and of indels falling inside the SSRs or
outside (referred to as Non-SSR indels). Large indels (.100 bp) or
insertion elements are indicated as ‘‘other’’ mutations. Mutations within
SSRs, either mononucleotide or polynucleotide (tandem repetition of
short DNA motives), are shown as detached slices. Slices corresponding
to mononucleotide G:C and A:T SSRs are shown in green.
doi:10.1371/journal.pone.0080514.g002
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G:C SSRs with length 8 bp in the pooled mutated genes was much
higher than the value for the predicted interval (p = 0.01). In
contrast, the frequencies of A:T SSRs in the prediction region vs.
the 60-gene pooled sequences were not significantly different
(Figure 4B). These findings indicate that long G:C SSRs were
functionally relevant during the genetic adaptation process of P.
aeruginosa because they made genes more prone to mutation.
In summary, in the environment of CF chronic lung infection, it
appears that mononucleotide G:C SSRs constitute length-depen-
dent hotspots for mutagenesis in various genes that are involved in
the genetic adaptation process of P. aeruginosa.
Mutagenesis in mononucleotide G:C SSRs, but not A:T
SSRs, is synergistically enhanced by stable
hypermutability during CF chronic lung infection
The genetic adaptation of P. aeruginosa to the airways of CF
patients is based primarily on mutational events. The process of
genetic adaptation has been suggested by Mena et al. to be
‘‘catalyzed’’ by MRS-deficient mutators through an increase in the
acquisition of adaptive mutations [9]. These authors observed a
tendency toward an increased proportion of small indels but
concluded that the incremental effect of hypermutability was not
biased toward any specific gene or any particular type of mutation.
They did not specifically examine the effect of hypermutability on
mononucleotide SSRs. In our previous studies, we used an MRS-
deficient mutator strain of P. aeruginosa to demonstrate in vitro that
the frequency and spectrum of mutagenesis of the mucA gene was
dependent on a G:C SSR of length 5 bp [7,8]. This finding poses
the question of whether hypermutability resulting from MRS
deficiency exerts a wide effect on the whole population of genomic
G:C SSRs in the context of CF chronic lung infection.
To study the specific in vivo effect of hypermutability on
mononucleotide SSRs, we followed a strategy similar to that of
Mena et al. [9]. These authors examined the association of
hypermutability with the 68 mutations (m1 to m68) that were
found to be accumulated in 35 isolates of P. aeruginosa strain
PACS2 collected over a period of 90 months of infection, as
described previously by Smith et al. [1]. The isolates collected after
54 months of infection were found to be MRS-deficient mutators.
We were thus able to perform a comparison between (i) the
mutations in mononucleotide G:C and A:T SSRs that occurred
during the first 54 months of infection, when the strain was non-
mutator (isolates 1 to 31) vs. (ii) the mutations that accumulated in
mononucleotide SSRs during the subsequent 36-month period
when the strain became mutator (isolates 32 to 35). We then
compared these findings with the general incremental effect of
hypermutability on other types of mutations. During the first 54
months of infection, 26 mutations were accumulated (m1 to m26).
Of these 26 mutations, 2 (7.7% of the total) were within G:C SSRs
and 1 (3.8%) was within A:T SSRs. During the subsequent 36-
month period when the strain became mutator, 42 new mutations
were observed, of which 7 (16.7%) occurred within G:C SSRs and
1 (2.4%) within A:T SSRs. Thus, when the strain was non-
mutator, the rate of accumulation of mutations per year was 0.4
for mononucleotide G:C SSRs, 0.2 for A:T SSRs, and 5.1 for
other types of mutation. During the mutator period, the
corresponding rate was 2.3 for G:C SSRs, 0.3 for A:T SSRs,
and 11.3 for other mutations. Thus, stable hypermutability
resulted in a 5.3-fold increase in the rate of accumulation of
mutations for G:C SSRs. This increase was notably greater than
that for A:T SSRs (1.5-fold) and for other mutations (2.2-fold)
(Figure 5).
Smith et al. [1] analyzed a set of 90 CF isolates collected from 29
patients (patients 2 to 30) with chronic P. aeruginosa infections.
These authors sequenced the coding and regulatory regions of 34
genes of the isolates and observed 155 mutations distributed in 22
genes and 9 additional mutations in the regulatory regions. Fifteen
of the 90 isolates were shown to be MRS-deficient mutators in a
subsequent study [9]. Thus, of the 164 recorded mutations, 66
were first observed in isolates that were mutators. These findings
Figure 3. Involvement of mononucleotide SSRs in genes involved in P. aeruginosa adaptation during CF chronic infection. The bar
graphs show (i) the percentages of the 60 genes mutated during CF lung chronic infection as reported by Smith et al. [1] that harbor mononucleotide
G:C SSRs (A) and A:T SSRs (B), relative to the length of the SSR (black bars); (ii) the percentages of those genes carrying mononucleotide SSRs that
were mutated during the process of chronic infection, relative to the length of the SSR (gray bars).
doi:10.1371/journal.pone.0080514.g003
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posed the question whether an association between hypermuta-
bility and mutagenesis in G:C or A:T SSRs existed in this set of
mutations. We found that of the 66 mutations in mutator strains, 7
(10.6%) corresponded to mutations in mononucleotide G:C SSRs.
This value was significantly higher (p = 0.031) than those for the
non-mutator isolates, which had 98 mutations of which only 2
(2.0%) occurred within G:C SSRs. A similar analysis of A:T SSRs
showed only 1 mutation (1.5%) in a mutator strain. This value was
not statistically different (p = 0.402) from that for non-mutators, in
which no such mutations were observed. These results are
consistent with those for patient 1 as above.
In order to extend these observations, we performed a new
analysis by using recent data obtained in our lab from the whole
genome sequencing of 27 MRS-deficient P. aeruginosa isolates from
two different CF patients (Feliziani et al., unpublished). This
analysis allowed the detection of highly mutated G:C SSRs that
could therefore play a relevant role in P. aeruginosa adaptation to
the CF lung. We chose three of the most frequently mutated G:C
SSRs found in the 27 genomes (Table S1) as candidates for further
analyses. Two of these G:C SSRs, a 7- and a 6-bp-long SSR, are
harbored in genes PA0929 and PA1127 respectively, and the third
(8 bp-long) is intergenic, located between genes PA4568 and
PA4569. Because these 27 isolates are all MRS-deficient mutators,
a comparison between mutators vs. non-mutators was not possible.
Furthermore, they belong only to two different clonal lineages (one
single linage per patient), thereby being difficult to distinguish
whether this high frequency of G:C SSR-mutations corresponds to
independent mutational events. In order to circumvent these
issues, we further analyzed the chosen G:C SSRs in a new set of 28
isolates obtained from 22 different CF patients with chronic airway
infection as described previously [13]. This collection contained
several different clones of mutator as well as non-mutator isolates
(10 MRS-deficient mutators and 18 non-mutators), thereby
allowing to establish whether mutagenesis of these SSRs is a
common feature among a clonally diverse set of isolates and
whether this phenomenon is associated with hypermutability or
not. It’s worth mentioning that previous to this analysis, we
confirmed that the candidate G:C SSRs were also fully conserved
Figure 4. Mononucleotide SSRs in the 60 mutated genes compared with the genome coding region of P. aeruginosa PACS2. The plots
show the numbers of mononucleotide G:C SSRs (A) and A:T SSRs (B) (normalized to SSR count every 105 bp) in the pooled coding sequence of the 60
genes mutated during the process of chronic infection (red curve) and in the 99% prediction region (grey area) estimated by re-sampling 60 genes at
random, with reposition, from the whole coding genome of P. aeruginosa PACS2. The sampling was repeated 50000 times to obtain a good
estimation of empirical distributions of SSR counts. From these distributions the extreme 0.5% and 99.5% quantiles were estimated to build the 99%
prediction intervals for each length of SSR. Points of the curve which fall outside of the prediction area were considered to be statistically significant
(p = 0.01).
doi:10.1371/journal.pone.0080514.g004
Figure 5. Genome-wide effect of MRS-deficient hypermutabil-
ity on the mutagenesis of mononucleotide SSRs. The bars show
the fold increase in the mutations per year that occurred in
mononucleotide G:C SSRs and A:T SSRs, and in other types of mutation
after P. aeruginosa PACS2 became mutator.
doi:10.1371/journal.pone.0080514.g005
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in reference strains of P. aeruginosa such as PAO1, PA14, PACS2,
2192, C3719, DK2 and LESB58 (whose sequences are available
online) to ensure that these G:C SSRs and their potential
mutations could be detected in the new set of isolates (Table S1).
Interestingly, mutagenesis in two of the three analyzed G:C
SSRs showed significant differences between the MRS-deficient
mutator and the non-mutator strains (p = 0.010). In this sense, not
a single G:C SSR mutation was found in the 18 non-mutator
isolates, whereas 40% of the mutator isolates showed indel
mutations in the PA0929 G:C SSR, 10% in PA1127 G:C SSR
and 40% in the PA4568//PA4569 intergenic G:C SSR (Figure
S2).
These findings, taken together, support the hypothesis that
becoming a MRS-deficient mutator is a matter of not only the
‘‘quantity’’ but also ‘‘quality’’ of mutations, through the preferen-
tial enhancement of mutagenesis in determinate hotspots, such as
mononucleotide G:C SSRs. The collected data suggest that in
non-mutator strains of P. aeruginosa mutagenesis in mononucleotide
G:C SSRs exerts a moderate impact on the adaptive process to the
airways of patients with chronic infection, whereas under a MRS-
deficient mutator background this phenomenon differs in regard
to the overall increase in mutation frequency. Paradoxically, such
an association was not observed in one of the most relevant cases
of G:C SSR mutagenesis in the course of CF chronic lung
infection: the -1 deletion in a 5-bp G:C SSR located in the mucA
gene, which leads to mucoid conversion [13–17]. We previously
demonstrated an association between this -1 deletion and
hypermutability in vitro [7,8]; however, such association was not
observed in the CF airway environment in vivo [13,18]. This
observation may be explained by the fact that the mucoid
phenotype is selected at earlier stages of the infection, usually
preceding the onset of MRS-deficient mutator strains [13,18,19].
Another possibility is that transient/stress-induced hypermutability
also plays a role in G:C SSRs mutagenesis. In P. aeruginosa and
other bacteria these motifs provide "hot" substrates for the
mutagenic activity of error-prone DNA polymerases, such as Pol
IV (dinB) [7,20].
Conclusions
P. aeruginosa is the most important pathogen in chronic infections
that occur in the airways of CF patients. Data from recent whole-
genome sequencing studies show that in order to persist, P.
aeruginosa undergoes a mutational adaptive process [1] that may be
promoted by the emergence of mutator strains [9]. We evaluated
the role of mononucleotide G:C and A:T SSRs in this adaptive
process. Our results suggest that evolutionary selective pressures
shaped the genome coding region of P. aeruginosa to prevent the
existence of long mononucleotide G:C SSRs. However, long G:C
SSRs that are still present are functionally relevant because they
make the genes in which they are harbored more prone to
mutation. The probability of mutation increased exponentially
with the length of the SSR. Although mutagenesis in G:C SSRs
may have a moderate impact on the whole ‘‘mutagenome’’ of non-
mutator strains, the impact becomes greater in strains that become
mutator because of MRS deficiency. We demonstrated a
significant association between MRS deficiency and the synergistic
increase in mutagenesis of mononucleotide G:C SSRs beyond the
general increase in other types of mutations. Considering that the
emergence of mutator strains is a frequent outcome in CF patients
[6], the virulence-associated genes that have long G:C SSRs are of
particular concern under a mutator background.
Materials and Methods
Data resources
Annotated sequences of the complete genomes of P. aeruginosa
strains PAO1 and PACS2 (Accession Numbers NC_002516 and
NZ_AAQW01000001, respectively) and of individual genes were
downloaded from the National Center for Biotechnology Infor-
mation (NCBI) (http://www.ncbi.nlm.nih.gov) or from the
Pseudomonas Genome Database [21] (http://www.pseudomonas.
com). The genomic sequence data of the 27 cystic fibrosis isolates
is publicly available at the European Nucleotide Archive
(Accession: ENA/SRA ERP002379) (http://www.ebi.ac.uk/ena).
Determination of SSR frequencies and distributions in the
genome of P. aeruginosa
The Coderet software available from the ‘‘Mobyle’’ site for
bioinformatic analysis [22] (http://mobyle.pasteur.fr/cgi-bin/
portal.py) was used to extract coding regions from the genome
sequence of P. aeruginosa. Scoring for SSRs at the genome level or
within individual genes was performed using the Simple Sequence
Repeats software [10] available at http://www.cmbl.uga.edu/
software.html. To determine the expected SSR counts, we used 8
predictive random models of diverse complexities. Of these, 2 were
homogeneous models (Bernoulli and first-order Markov) and 6
were heterogeneous models (b-b, b-bp, m1-m1, m1-m1p, m1c,
and m1-c1), as described previously [10]. Unlike homogeneous
models, heterogeneous models represent the compositional
dissimilarities found in the coding vs. non-coding sequences of
the genome. These models distinguish coding from non-coding
DNA, break down the genomic sequences to generate random
simulations for each region separately, and finally reassemble the
randomized sequences of both regions. For both the homogeneous
and heterogeneous models, the expected SSR count was the
average of 10 simulations. The curves from different random
models provided a range of expected SSR counts, as described
previously [5,10].
Determination of prediction intervals for SSR frequencies
To test for the hypothesis that the SSR frequencies are the same
within the pool of mutated genes as in the whole coding genome, a
99% prediction interval for each G:C and A:T SSR length was
estimated by a re-sampling technique. A set of 50000 samples
containing 60 genes each (the number of genes in the pool of
mutated genes) was taken at random, with reposition, from the
whole coding genome. For each sample the counts of mononu-
cleotide G:C and A:T SSRs of length 1 to 9, normalized to a
length of 105 bp, were recorded. From the empirical distributions
of (normalized) SSR counts the extreme 0.5% and 99.5%
quantiles were estimated to build the 99% prediction intervals
for each length of SSR. The procedure is an ad hoc algorithm
implemented in R 3.0.1 [23].
Sequence analysis of the PA0929 and PA1127 genes, and
the PA4568//PA4569 intergenic region
Genomic DNA of P. aeruginosa CF isolates [13] was extracted by
using a DNA isolation kit (QIAGEN). Because mononucleotide
SSRs are prone to slippage-errors during PCR amplification steps,
the reactions were performed with Pfu DNA polymerase enzyme
(Fermentas) which possesses 39R59 exonuclease (proofreading)
activity that enables the polymerase to correct nucleotide
incorporation errors. PCR amplification and DNA sequencing were
carried out using primers 0929-F (59-GACGATTATCTGCC-
GAAGCCT-39) and 0929-R (59-GGTATTCGGTCGGCGTCA-
SSRs and Mismatch Repair in Pseudomonas aeruginosa
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39) for PA0929, 1127-F (59-GCAAGTCCGACCCGAAGTT-39)
and 1127-R (59-GTCCTTGAGAAAAACCGCCA-39) for PA1127,
and 4568//4569-F (59-TAAACCTGCTCACCCGACG-39) and
4568//4569-R (59-TGTAGCCCAGGGTCTTGCC-39) for the
PA4568//PA4569 intergenic region. PCR amplifications were
performed under the following conditions: 8 min at 95uC, 33 cycles
of 1 min at 94uC, 1 min 20 sec at 60uC, 2 min at 72uC, and a final 10
min-extension at 72uC. The PCR products were cleaned with a Gel
Purification kit (QIAGEN) and both strands were directly sequenced
by using the same PCR primers (DNA Sequencing Facility,
University of Chicago).
Statistical analysis
The data were analyzed by the two-sided Fisher’s exact test
using GraphPad Instat software. Differences were considered
statistically significant for p, 0.05.
Supporting Information
Figure S1 Mononucleotide SSRs in the P. aeruginosa
PACS2 coding and non-coding genome regions. The plots
show the counts of mononucleotide SSRs in the coding and non-
coding regions of the genome (red circles) and in random
sequences generated by various predictive models (black symbols),
as described in Methods.
(TIF)
Figure S2 Association between MRS-deficient hypermu-
tability and mutagenesis in three selected G:C SSRs. Bars
indicate the percentage of mutator (gray bars) and non-mutator
(black bars) P. aeruginosa CF isolates that harbored indel mutations
in three selected G:C SSRs, located in genes PA0929, PA1127 and
the intergenic region PA4568//PA4569. Statistically significant
differences (p, 0.05) are indicated by * (two-sided Fisher’s exact
test).
(TIF)
Table S1 Selected G:C SSRs which were frequently
mutated in the genomes of P. aeruginosa isolates from
CF patients.
(TIF)
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